Ironwood Pharmaceuticals (IRWD) Reports In-Line Q2 Loss
Tweet
Share
E-mail
Ironwood Pharmaceuticals (NASDAQ: IRWD) reported Q2 loss of ($0.19), in-line with the analyst estimate of ($0.19). Revenue for the quarter came in at $11.26 million versus the consensus estimate of $10.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Dave & Buster's Entertainment (PLAY) Misses Q2 EPS by 46c
- Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
